Jörn-Sven Kühl

5PUBLICATIONS
99CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
Allogeneic hematopoietic cell transplantation is curative in CARMIL2 deficiency.

|Jul 12, 2026
An intervention for fear of progression in childhood cancer patients and their parents: feasibility and preliminary efficacy in a pilot randomised controlled trial.

|Jun 06, 2026
Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow-Up Care.

|Aug 14, 2025
Psychometric Properties of the Fear of Progression Questionnaire for Children in Two German Samples (Acute Treatment and Follow-Up Care).

Florian Schepper, Anja Santel, Jessy Herrmann

|Dec 14, 2022
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.

Romain Lévy, Florian Gothe, Mana Momenilandi

Pageof 1

Frequent Collaborators

3 joint publications

Leonard Konstantin Kulisch

3 joint publications

Kristina Herzog

3 joint publications

Florian Schepper

3 joint publications

Jessy Herrmann